BAY-8002 is used in research and development for cancer therapeutics, particularly in inhibiting the growth of cancer cells and inducing apoptosis. Additionally, studies explore its potential in combination with other treatments, such as chemotherapy or radiation therapy, to enhance efficacy in destroying cancer cells. BAY-8002 is currently in clinical trial stages to evaluate safety and efficacy before widespread medical use.